Abstract
We have investigated theHLA-DRB and -DQB gene polymorphism in 131 myasthenia gravis (MG) patients. TheHLA genotypes in these patients were assigned by means of restriction fragment length polymorphism (RFLP)-definedDR-DQ haplotypes, correlating to serologic HLA class II typing. Using this technique we could, among randomly selected non-thymomatous (NT)-MG patients, confirm the strong association to DR3, and 70% of the patients were found to carry a specific DR3-positiveDR-DQ haplotype,T-3.1. Furthermore, an analysis of T-3.1− NT-MG patients revealed that 59 % were T-4.1÷ (DR4, DQw8). Thymic hyperplasia was found in approximately 85 % of the T-3.1+ , as well as of the T-4.1+ /3.1− patients. As previously observed, we found a clear dominance of females among the T-3.1+ NT-MG patients. However, among T-4.1+/3.1- patients, males were as common as females. Furthermore, the T-4.1+ patients were significantly older at the onset of disease than those who were T-3.1+. In female MG patients, the DRwl5-Dw2-positive haplotypeT-2.1 was strongly correlated with the presence of thymoma (T-MG). These data indicate that the HLA associations in early vs late onset of NT-MG are different, and that female patients with and without thymoma differ from each other with regard to HLA markers. Thus, at least three different HLA DR-DQ associations are found in subgroups of idiopathic MG.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Almon, R. R., Andrew, C. G., and Appel, S. H.: Serum globin in myasthenia gravis: inhibition of α-bungarotoxin binding to acetylcholine receptors.Science 186: 55–57, 1974
Baur, M. P., Neugebauer, M., and Albert, E. D.: Reference tables of three-locus haplotype frequencies and delta values in Caucasians, Orientals and Negroids.In E. D. Albert, M. P. Baur, and W. R. Mayr (eds.):Histocompatibility Testing, pp. 756–760, Springer, Berlin, 1984
Bell, J., Smoot, S., Newby, C., Toyka, K., Rassenti, L., Smith, K., Hohlfeld, R., McDevitt, H., and Steinman, L.: HLA-DQ betachain polymorphism linked to myasthenia gravis.Lancet 1 1058–1060, 1986
Bergström, K., Franksson, C., Matell, G., Nilsson, B. Y., Persson, A., von Reis, G., and Stensman, R.: Drainage of thoracic duct lymph in twelve patients with myasthenia gravis.Ear Neurol 13 19–30, 1975
Bidwell, J. L.: DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens.Immunol Today 9 18–23, 1988
Böhme, J., Carlsson, B., Wallin, J., Möller, E., Persson, B., Peterson, P. A., and Rask, L.: Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes.J Immunol 137 941–947, 1986
Brocke, S., Brautbar, C., Steinman, L., Abramsky, O., Rothbard, J., Neumann, D., Fuchs, S., and Mozes, E.: In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class 11 genes.J Clin Invest 82: 1894–1900, 1988
Carlsson, B., Wallin, J., Böhme, J., and Möller, E.: HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology.Hum Immunol 20: 95–113, 1987
Cohen, D., Paul, P., Le Gall, I., Marcadet, A., Font, M. P., Cohen-Haguenauer, O., Sayagh, B., Cann, H., Lalouel, J. M., and Dausset, J.: DNA polymorphism of HLA class I and class II regions.Immunol Rev 85: 87–105, 1985
Cohen-Haguenauer, O., Robbins, E., Massart, C., Busson, M., Deschamps, I., Hors, J., Lalouel, J. M., Dausset, J., and Cohen, D.: A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.Proc Nod Acad Sci USA 82: 3335–3339, 1985
Compston, D. A. S., Vincent, A., Newsom-Davis, J., and Batchelor, J. R.: Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.Brain 103: 579–601, 1980
Feltkamp, T. E. W., Van den Berg-Loonen, P. M., Nijenhuis, L. E., Oosterhuis, H. J. G. H., Engelfriet, C. P., Van Rossum, A. L., and Van Loghem, J. J.: Relations between HL-A antigens, myastheniagravis and autoantibodies.In K. Kunze and J. E. Desmeth (eds.):Studies on Neuromuscular Diseases, pp. 180–185, Karger, Basel, 1975
Fritze, D., Herrman, C., Jr., Nacim, F., Smith, G. S., and Walford, R. L.: HL-A antigens in myasthenia gravis.Lancet 1: 240–242, 1974
Grosse-Wilde, H., Toyka, K. V., Besinger, U. A., Doxiadis, I., Heininger, K., Hömberg, M., Hömberg, V., Hohlfeld, R., Fatch-Moghadam, A., Jungwirth, J., Kreeb, G., and Vögeler, U.: Zur Immungenetik der Myasthenia gravis.Dtsch med Wochenschr 108: 694–700, 1983
Gustafsson, K., Wiman, K., Emmoth, E., Larhammar, D., Böhme, J., Hyldig-Nielsen, J. J., Ronne, H., Peterson, P. A., and Rask, L.: Mutations and selection in the generation of class II histocompatibility antigen polymorphism.EMBO J 3: 1655–1661, 1984
Harcourt, G. C., Sommer, N., Rothbard, J., Willcox, H. N., and Newsom-Davis, J.: A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.J Clin Invest 82: 1295–1300, 1988
Hohlfeld, R., Toyka, K. V., Miner, L. L., Walgrave, S. L., and Conti-Tronconi, B. M.: Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis.J Clin Invest 81: 657–660, 1988
Kaakinen, A., Pirskanen, R., and Tiilikainen, A.: LD-antigens associated with HL-A8 and myasthenia gravis.Tissue Antigens 6: 175–182, 1975
Kappes, D. and Strominger, J. L.: Human class II major histocompatibility complex genes and proteins.Annu Rev Biochem 57: 991–1028, 1988
Larhammar, D., Schenning, L., Gustafsson, K., Wiman, K., Claesson, L., Rask, L., and Peterson, P. A.: Complete amino acid sequence of an HLA-DR antigen-like β chain as predicted from the nucleotide sequence: similarities with immunoglobulin and HLA-A, -B, and -C antigens.Proc Natl Acad Sci USA 79: 3687–3691, 1982
Lindstrom, J., Shelton, D., and Fujii, Y.: Myasthenia gravis.Adv Immunol 42: 233–284, 1988
Möller, E., Hammarström, L., Smith, E., and Matell, G.: HL-A8 and LD-8a in patients with myasthenia gravis.Tissue Antigens 7: 39–44, 1976
Nastuk, W. L., Plescia, O. J., and Osserman, K. E.: Changes in serum complement activity in patients with myasthenia gravis.Proc Soc Exp Biol Med 105: 177–184, 1960
Oksenberg, J. R., Sherrit, M., Begovich, A. B., Erlich, H. A., Bernard, C. C., Cavalli-Sforza, L. L., and Steinman, L.: T-cell receptor Vol and Ca alleles associated with multiple sclerosis and myasthenia gravis.Proc Natl Acad Sci USA 86: 988–992, 1989
Olerup, O., Hillert, J., Frederiksson, S., Olsson, T., Kam-Hansen, S., Möller, E., Carlsson, B., and Wallin, J.: Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.Proc Natl Acad Sci USA 86: 7113–7117, 1989
Oosterhuis, H. J. G. H.:Myasthenia Gravis, Clinical Neurology and Neurosurgery Monographs, Vol 5, Churchill Livingstone, Edinburgh, London, Melbourne, New York, 1984
Pirskanen, R., Tiilikainen, A., and Hokkanen, E.: Histocompatibility (HL-A) antigens associated with myasthenia gravis.Ann Clin Res 4: 304–306, 1972
Sette, A., Buus, S., Appella, E., Smith, J. A., Chesnut, R., Miles, C., Colon, S. M., and Grey, H. M.: Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.Proc Natl Acad Sci USA 86: 3296–3300, 1989
Simpson, J. A.: Myasthenia gravis: a new hypothesis.Scott Med J 5: 419–436, 1960
Smith, C. I. E., Carlsson, B., Hammarström, L., Matell, G., Möller, E., Pirskanen, R., and Wallin, J.: Analysis of HLA DR and DQ β-genes in myasthenia gravis patients.Ann NY Acad Sci 505: 816–819, 1987a
Smith, C. I. E., Borgonovo, L., Carlsson, B., Hammarström, L., and Rabbitts, T. H.: Molecular probing of disease susceptibility genes in myasthenia gravis patients: an analysis of T-cell receptor and HLA class II genes using restriction fragment length polymorphism.Ann NY Acad Sci 505: 388–397, 1987b
Termijtelen, A., Gorski, J., Robbins, F. M., Tanigaki, N., Tosi, R., Tilanus, M. G., Schroeijers, W. E., and van Rood, J. J.: Correlations between polymorphisms at the DNA and at the protein level of DRw52 haplotypes, revealed with a variety of techniques.Hum Immunol 22: 171–178, 1988
Tilanus, M. G., Hongming, F., van Eggermond, M. C., van der Bijl, M., D'Amaro, J., Schreuder, G. M., de Vries, R. R., and Giphart, M. J.: An overview of the restriction fragment length polymorphism of the HLA-D region: its application to individual D-, DRtyping by computerized analyses.Tissue Antigens 28: 218–227, 1986
Tiwari, J. L. and Terasaki, P. L:HLA and Disease Associations, Springer, New York, 1985
Todd, J. A., Acha-Orbea, H., Bell, J. I., Chao, N., Fronek, Z., Jacob, C. O., McDermott, M., Sinha, A. A., Timmerman, L., Steinman, L., and McDevitt, H. O.: A molecular basis for MHC class IIassociated autoimmunity.Science 240: 1003–1009, 1988
Toyka, D. G., Drachman, D. B., Pestronk, A., and Kao, I.: Myasthenia gravis: passive transfer from man to mouse.Science 190: 397–399, 1975
van den Berg-Loonen, E. M., Nijenhuis, L. E., Engelfriet, C. P., Feltkamp, T. E. W., van Rossum, A. L., and Oosterhuis, H. J. G. H.: Segregation of HLA haplotypes in 100 families with a myasthenia gravis patient.J Immunogenet 4: 331–340, 1977
Wallin, J., Carlsson, B., Ström, H., and Möller, E.: A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis.Arthritis Rheum 31: 72–79, 1988
Wallin, J., Carlsson, B., Olerup, O., and Möller, E.: Individuals with HLA-DR blank alleles display well-known DR-DQ RFLPs.Tissue Antigens 34: 9–16, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carlsson, B., Wallin, J., Pirskanen, R. et al. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis. Immunogenetics 31, 285–290 (1990). https://doi.org/10.1007/BF02115001
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02115001